Filtered By:
Specialty: Health Management
Drug: Proton Pump Inhibitors PPIs
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Cost-Effectiveness of Proton Pump Inhibitor Co-Therapy in Patients Taking Aspirin for Secondary Prevention of Ischemic Stroke
Conclusions
Co-therapy with ASA plus PPI appears to be cost-effective compared with ASA monotherapy. The addition of PPI also appeared to prolong the duration of ASA therapy, thereby reducing the risk of ischemic stroke.
Source: PharmacoEconomics - October 1, 2015 Category: Health Management Source Type: research
